Full Press Release Details
IDEAYA Biosciences Appoints Darrin M Beaupre, M D , Ph D , as Chief Medical Officer to Lead Clinical Development of Expanding Clinical Pipeline.
IDYA
IDEAYA Biosciences Appoints Darrin M Beaupre, M D , Ph D , as Chief Medical Officer to Lead Clinical Development of Expanding Clinical Pipeline
Key Takeaway: IDEAYA Biosciences Appoints Darrin M Beaupre, M D , Ph D , as Chief Medical Officer to Lead Clinical Development of Expanding Clinical Pipeline
Price reaction · baseline $17.58 (2022-11-25 close) · 1 other IDYA headline(s) in the window, move may be shared
day 0 close · peak
-6%
day 1
-2.2%
day 3
+1.1%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+47%
120-day peak, hindsight
Typical move
5.2%
average across 6 past catalysts
Cash runway
~42 mo
Minimal dilution risk
Lead asset
IDE892
Phase 1 · NSCLC Adenocarcinoma